期刊文献+

子宫内膜癌肉瘤4例临床病理学分析

Clinicopathological analysis of 4 cases of endometrial carcinosarcoma
下载PDF
导出
摘要 目的子宫内膜癌肉瘤为侵袭性和双相性肿瘤,本文探讨子宫内膜癌肉瘤的临床病理学特征及患者预后情况,为临床诊疗提供依据。方法复习4例子宫内膜癌肉瘤的临床及病理学资料,行常规石蜡包埋切片和免疫组化染色协助诊断。结果显微镜下见肿瘤组织由恶性上皮和间叶2种组织成分构成,相互之间有或穿插移行或分界清楚,上皮成分为子宫内膜样癌,肉瘤成分为横纹肌肉瘤。所有上皮成分AE1/AE3(+)、ER(+),所有肉瘤成分vimentin(+)、MyoD1(+)。结论子宫内膜癌肉瘤是侵袭性肿瘤,预后差。组织形态学结合免疫组化染色对诊断及鉴别诊断有重要的意义。 Objective Endometrial carcinosarcoma is an aggressive and biphasic tumor.This article discusses the clinicopathological features and prognosis of endometrial carcinosarcoma,and provides a basis for clinical diagnosis and treatment.Methods The clinical and pathological data of 4 cases of endometrial carcinosarcoma were reviewed,and routine paraffin sections and immunohistochemical staining were performed to assist in the diagnosis.Results Microscopically,the tumor tissue was composed of malignant epithelium and mesenchyme,which were interspersed with each other or had clear boundaries.The epithelial component was endometrioid carcinoma,and the sarcoma component was rhabdomyosarcoma.All epithelial components AE1/AE3(+),ER(+),all sarcoma components vimentin(+),MyoD1(+).Conclusion Endometrial carcinosarcoma is an aggressive tumor with poor prognosis.Histomorphology combined with immunohistochemical staining is of great significance for diagnosis and differential diagnosis.
作者 景彩萍 何朵 赵雪艳 霍媛媛 JING Caiping;HE Duo;ZHAO Xueyan;HUO Yuanyuan(Department of Pathology,Yan´an People´s Hospital,Yan´an 716000,China)
出处 《延安大学学报(医学科学版)》 2022年第3期75-78,共4页 Journal of Yan'an University:Medical Science Edition
关键词 子宫内膜 癌肉瘤 临床病理 诊断 Endometrial Carcinosarcoma Clinicopathology Diagnosis
  • 相关文献

参考文献4

二级参考文献26

  • 1陈鲁,陈曦,吴伟,羊正炎,高永良.卵巢癌肉瘤临床病理特征及其与预后的关系[J].浙江医学,2009(11). 被引量:2
  • 2Sumathi VP,Murnaghan M,Dobbs SP,et al.Extragenital müllerian carcinosarcoma arising from the peritoneum:report of two cases[J].Int J Gynecol Cancer,2002,12(6):764-767.
  • 3Sarah Yousaf Chaudhary,Fazal Ilahi,Ambreen Moatasim,et al.Uterine carcinosarcoma,an unusual histologic presentation[J].Rawal Med J,2009,34(1):120-122.
  • 4Gadduci A,Cosio S,Romanini A,et al.The management of patients with uterine sarcoma:A debated critical challenge[J].Crit Rev Oncol Hematol,2008,65(2):129-142.
  • 5Kernochan LE,Garcia RL.Carcinosarcomas(malignant mixed Mullerian turmor)of the uterus:advances in elucidation of biologic and clinical characteristics[J].J Natl Compr Canc Netw,2009,7(5):550-556.
  • 6de Brito PA,Silverberg SG,Orenstein JM.Carcinosarcoma(malignant mixed müllerian(mesodermal)tumor)of the female genital tract:immunohistochemical and ultrastructural analysis of28 cases[J].Hum Pathol,1993,24(2):132-142.
  • 7Watanabe M,Shimizu K,Kato H,et al.Carcinosarcoma of the uterus:immunohistochemical and genetic analysis of clonality of one case[J].Gynecol Oncol,2001,82(3):563-567.
  • 8Gorai I,Yanagibashi T,Taki A,et al.Uterine carcinosarcoma is derived from a single stem cell:an in vitro study[J].Int J Cancer,1997,72(5):821-827.
  • 9Rauh-Hain JA,Shoni M,Schorge JO,et al.Prognostic determinants in patients with uterine and ovarian carcinosarcoma[J].J Reprod Med,2013,58(7-8):297-304.
  • 10Park HJ,Kim HJ,Wu HG,et al.The influence of adjuvant radiotherapy on patterns of failure and survivals in uterine carcinosarcoma[J].Radiat Oncol J,2011,29(4):228-235.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部